Related Experiment Video
Updated: Jul 2, 2026

Population and Single-Cell Analysis of Antibiotic Persistence in Escherichia coli
Published on: March 24, 2023
[Ofloxacin is contraindicated in case of G6PD deficiency: is it evidenced based?]
T Carmoi1, L Bordier, S Bonnefoy
1Service de médecine interne, HIA Val-de-Grâce, 74, boulevard de Port-Royal, 75005 Paris, France. t.carmoi@wanadoo.fr
Abstract:
G6PD deficiency is very frequent with almost 400 millions of patients worldwide in Asia, Africa and Mediterranean. G6PD deficiency is involved in mild or severe haemolysis and the precipitating factor is usually a drug. More than 100 drugs have been implicated and fluoroquinolones are one of the more classic. However, the literature review shows that only a few observations have been clearly documented.
Related Concept Videos
Inhibitors of Bacterial DNA Synthesis
Rocky Mountain Spotted Fever
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

